Experience When It Matters Most

Our statewide physician network includes nationally recognized experts in cancer care and research—experience you want and deserve when it matters most.

Have a question? Call the clinic location closest to you, or our main number, 1-888-259-7622.

Comprehensive Care, Proven Outcomes

Since 1992, Rocky Mountain Cancer Centers (RMCC) has been a leader in cancer care. We began as a small group practice of six physicians with a new approach to treating cancer—administering chemotherapy on an outpatient basis—and have since developed into Colorado's largest and most comprehensive provider of cancer care with 58 physicians treating patients in 20 community-based locations across the state.

Through our culture of respect and collaboration we practice evidence-based medicine and participate in clinical research to create value and positive outcomes for our patients and families, referring physicians and payers.

Why Choose Us

Expertise in Rare and Common Cancers

No matter what cancer type you've been diagnosed with our team of nationally recognized doctors and support providers are here to help with personalized treatment plans that include the most advanced treatment options and therapies.

Experience When It Matters Most

Our statewide physician network includes nationally recognized experts in cancer care and research—experience you want and deserve when it matters most.

View All Providers

Cancer Care Close To Home

With 20 outpatient cancer treatment centers across Colorado, we provide convenient, cost-effective, comprehensive cancer care close to home. Our state-of-the-art facilities have everything you need to fight cancer.

Research Trials

A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies [CheckMate370]

PURPOSE OF THIS CLINICAL RESEARCH TRIAL A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies [CheckMate370] MORE DETAILS ON THIS LUNG CANCER TRIAL USON 14158

Read More

Treatment and Services

Genetic Testing

Are you concerned about your risk for cancer? Our board certified genetic counselors can help you learn about hereditary and other risks factors for cancer, as well as explain recent advances in cancer screening, cancer risk reduction strategies and genetic testing. Together with our medical oncologists they provide medical management recommendations and support for patients who have been diagnosed with or are at high risk for developing cancers such as breast, colorectal, prostate, gastrointestinal, uterine , ovarian and other cancers

Read More

Recent News

New Report Details Impact Of Race and Tumor Subtype on Breast Cancer Recurrence

What is known is that women with breast cancer are at increased risk of a second malignancy (SM). What until recently was not known was the role race and hormone receptor (HR) status play in that SM. In a recently published article in SpringerPlus, co-authors RMCC medical oncologist Dr. Sami Diab and genetic counselors Barbara Hamlington and Laura Brzeskiewicz report that clinical and biological differences between Caucasian and African American women do indeed impact the risk of disease recurrence. The study found that African American women with breast cancer are more likely to be younger at diagnosis, carry hormone receptor (HR)-negative breast cancer, present with more advanced stage at diagnosis and have higher rates of BRCA1/2 mutations, all factors that can increase their risk of breast cancer recurrence and non-breast second malignancy. Read More